Epigenetic modulation as a therapy in systemic sclerosis
Sign Up to like & getrecommendations! Published in 2019 at "Rheumatology"
DOI: 10.1093/rheumatology/key071
Abstract: SSc is an autoimmune idiopathic disease in which there is an inflammatory component driving fibrosis. The chief cell involved is the myofibroblast, which when activated secretes copious amounts of extracellular matrix that forms deposits, leading… read more here.
Keywords: therapy systemic; fibrosis; systemic sclerosis; rheumatology ... See more keywords